tiprankstipranks
Resmed (RMD)
NYSE:RMD
US Market

Resmed (RMD) Income Statement

Compare
1,037 Followers

Resmed Income Statement

Last quarter (Q2 2025), Resmed's total revenue was $1.28B, an increase of 10.26% from the same quarter last year. In Q2, Resmed's net income was $344.62M. See Resmed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 4.69B$ 4.22B$ 3.58B$ 3.20B$ 2.96B
Gross Profit
$ 2.66B$ 2.36B$ 2.02B$ 1.84B$ 1.72B
Operating Expenses
$ 1.34B$ 1.20B$ 1.02B$ 926.75M$ 908.73M
Depreciation and Amortization
$ 216.21M$ 196.52M$ 193.84M$ 191.52M$ 181.37M
EBITDA
$ 1.53B$ 1.36B$ 1.18B$ 1.10B$ 990.43M
Operating Income
$ 1.32B$ 1.13B$ 1.00B$ 903.68M$ 809.66M
Other Income/Expenses
$ -55.09M$ -30.21M$ -39.80M$ -20.02M$ -76.57M
Pretax Income
$ 1.26B$ 1.10B$ 960.48M$ 883.66M$ 733.09M
Net Income
$ 1.02B$ 897.56M$ 779.44M$ 474.50M$ 621.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 6.94$ 6.12$ 5.34$ 3.27$ 4.31
Diluted EPS
$ 6.92$ 6.09$ 5.30$ 3.24$ 4.27
Weighted Average Shares Outstanding
147.02M 146.76M 146.07M 145.31M 144.34M
Weighted Average Shares Outstanding (Diluted)
147.55M 147.46M 147.04M 146.45M 145.65M
Currency in USD

Resmed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis